Related Experiment Video
Updated: Apr 14, 2026
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress
Elizabeth M Molyneux1, Queen Dube, Laura Newberry
1Department of Paediatrics, College of Medicine and Queen Elizabeth Central Hospital, Blantyre, Malawi.
Insights
Improving neonatal care is crucial for reducing under-five mortality, as bacterial meningitis disproportionately affects newborns. Enhanced diagnosis and treatment strategies are vital for better outcomes in African neonates.
Area of Science:
- Neonatal health
- Infectious diseases
- Public health in Africa
Background:
- Under-five mortality (UFM) has decreased, but neonatal mortality rates lag behind, particularly in African regions.
- Bacterial meningitis is a significant, often underdiagnosed, cause of mortality and morbidity in African newborns.
- Improving neonatal care quality is essential for further reductions in UFM.
Purpose of the Study:
- To review recent advancements in the diagnosis, treatment, and outcomes of bacterial meningitis in African newborns.
- To highlight the need for improved neonatal care in first referral hospitals.
- To evaluate current and future strategies for combating neonatal bacterial meningitis.
Main Methods:
- Review of recent literature on neonatal bacterial meningitis diagnosis and treatment.
- Evaluation of evolving etiological patterns of bacterial meningitis in neonates.
- Assessment of current antimicrobial and adjuvant therapies and prevention programs.
Main Results:
- Challenges in laboratory-confirmed diagnosis of bacterial meningitis in neonates.
- Development of simpler, bedside diagnostic tools.
- Shifting patterns in causative bacteria, necessitating reconsideration of first-line antimicrobial therapies.
- Identification of risk reduction and prevention programs for neonatal infections.
Conclusions:
- Essential improvements in neonatal care at first referral hospitals using simple, low-cost, validated interventions.
- Re-evaluation of first-line antibiotic therapy due to rising multidrug-resistant and Gram-negative bacterial infections.
- Need for further research on optimal antimicrobial therapy duration, adjuvant treatments, and anticonvulsant efficacy.
Purpose Of Review:
There has been a reduction in overall under fives mortality (UFM) but neonatal mortality has not fallen at the same rate as for older children. Bacterial meningitis remains a common, often unrecognized and devastating illness in many African newborns with high mortality and morbidity. Further progress in reducing UFM has to focus on quality of care for neonates. Recent efforts to improve diagnosis, treatment and outcome are reviewed.
Recent Findings:
Diagnosis is often unsupported by laboratory tests and efforts have been made to improve the clinical diagnosis of bacterial meningitis. Simpler, robust bedside tests are being devised. The cause of bacterial meningitis is changing and first-line antimicrobial therapy and adjuvant therapies are evaluated. Programmes to reduce risk factors and prevent neonatal infections are identified.
Summary:
Neonatal care needs to improve in first referral hospitals with simple, low-cost, validated measures provided as bundles of care for both mother and child. First-line antibiotic therapy must be reconsidered in the light of increased infections by multiresistant and Gram-negative bacteria. Studies are needed for effective and safe lengths of antimicrobial therapy, the role of adjuvant therapy and the best anticonvulsants to use.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
01:18Viral Meningitis
01:28Development of the Oral Microbiota